Benitec Biopharma Ownership | Who Owns Benitec Biopharma?
Benitec Biopharma Ownership Summary
Benitec Biopharma is owned by 16.25% institutional investors, 2.74% insiders, and 81.01% retail investors. Suvretta capital management is the largest institutional shareholder, holding 27.28% of BNTC shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.70% of its assets in Benitec Biopharma shares.
BNTC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Benitec Biopharma | 16.25% | 2.74% | 81.01% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 9.88M | 27.28% | $138.57M |
| Franklin resources | 2.59M | 7.15% | $36.33M |
| Adage capital partners gp | 1.97M | 5.45% | $27.67M |
| Vanguard group | 992.11K | 2.74% | $13.92M |
| Blackrock funding, inc. /de | 945.51K | 2.61% | $13.27M |
| Nantahala capital management | 838.10K | 2.31% | $11.76M |
| Infinitum asset management | 500.00K | 1.38% | $7.01M |
| Geode capital management | 438.50K | 1.21% | $6.15M |
| Silverarc capital management | 276.27K | 0.76% | $3.88M |
| Schonfeld strategic advisors | 260.42K | 0.72% | $3.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 62.00K | 4.94% | $869.86K |
| Suvretta capital management | 9.88M | 3.55% | $138.57M |
| Infinitum asset management | 500.00K | 1.29% | $7.01M |
| Silverarc capital management | 276.27K | 0.52% | $3.88M |
| Nantahala capital management | 838.10K | 0.41% | $11.76M |
| Awm investment company | 182.98K | 0.24% | $2.57M |
| Myda advisors | 70.00K | 0.21% | $982.10K |
| Longaeva partners | 37.54K | 0.08% | $526.64K |
| Adage capital partners gp | 1.97M | 0.04% | $27.67M |
| Schonfeld strategic advisors | 260.42K | 0.02% | $3.65M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 945.51K | 0.00% | 226.82K |
| Goldman sachs group | 194.36K | 0.00% | 173.37K |
| Ubs group | 99.94K | 0.00% | 82.06K |
| State street | 218.40K | 0.00% | 57.33K |
| Awm investment company | 182.98K | 0.24% | 45.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | 2.59M | 0.01% | -111.81K |
| Marshall wace, llp | - | - | -43.00K |
| Eam investors | - | - | -37.81K |
| Hrt financial lp | - | - | -25.93K |
| Qube research | - | - | -19.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Russell investments group | 5.62K | 0.00% | 5.62K | $78.78K |
| Simplex trading | 72.00 | - | 72.00 | $1.00K |
| Srs capital advisors | 24.00 | - | 24.00 | $337.00 |
| Pnc financial services group | 5.00 | - | 5.00 | $70.00 |
| Sbi securities | 1.00 | - | 1.00 | $14.00 |
Sold Out
| Holder | Change |
|---|---|
| Eversource wealth advisors | -148.00 |
| Acadian asset management | -1.82K |
| Balyasny asset management | -2.82K |
| Sg americas securities | -8.46K |
| Xtx topco | -10.85K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 33 | -37.74% | 5,883,256 | -74.00% | 16 | 0.47% | 19 | -45.71% | 6 | -45.45% |
| Jun 30, 2025 | 56 | 51.35% | 22,685,531 | 3.62% | 58 | 1.83% | 37 | 42.31% | 12 | 100.00% |
| Mar 31, 2025 | 36 | 20.00% | 21,891,366 | 15.23% | 56 | 0.77% | 25 | 8.70% | 6 | 50.00% |
| Dec 31, 2024 | 30 | 20.00% | 18,997,897 | 38.52% | 86 | 0.52% | 23 | 91.67% | 4 | -50.00% |
| Sep 30, 2024 | 25 | 31.58% | 13,715,023 | 115.83% | 128 | 3.36% | 12 | -20.00% | 8 | 300.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.50M | 5.70% | - |
| HBM Healthcare Investments AG Ord | 1.19M | 4.54% | - |
| Franklin Biotechnology Discovery A | 1.15M | 4.38% | -55.29K |
| Vanguard Total Stock Mkt Idx Inv | 495.12K | 1.89% | -10.91K |
| Janus Henderson Hrzn Biotec E2 USD | 424.25K | 1.62% | -16.16K |
| iShares Russell 2000 ETF | 324.08K | 1.23% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 233.91K | 0.89% | -98.52K |
| Fidelity Small Cap Index | 145.41K | 0.55% | 145.41K |
| iShares Russell 2000 Growth ETF | 123.00K | 0.47% | - |
| Fidelity Extended Market Index | 115.50K | 0.44% | -950.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 07, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $10.14M | |
| Nov 07, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $9.86M | |
| Mar 31, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $120.02K | |
| Mar 31, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $66.85K | |
| Mar 31, 2025 | SUVRETTA CAPITAL MANAGEMENT, LLC | Buy | $8.86K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 2 | - |
| 2025 Q1 | 6 | - |
| 2024 Q4 | 10 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
BNTC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools